KOR

e-Article

A Phase I Study of Apolizumab, an Anti-HLA-DR ss-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies
Document Type
Journal
Source
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS; JUL 2022, 45 7, p294-p297, 4p.
Subject
Language
English
ISSN
1537453X